Skip to content
Menu

Alamar Biosciences, Inc. ALMR

Full chart Compare
Set alert

Price alert · ALMR

All alert types
26.99 USD -1.69 (-5.89%)

As ofNov 20, 2026, 1:26 PM EST

26.41 Day range 28.22
18.85 52-week range 39.61
YTD
+22.68%
1 year
+22.68%

5D -1.14 (-3.59%)

303132WedThuFriMonTue30.64
Market cap
1.88B
Revenue (ttm)
114.05M
Profit margin
-48.22%
EPS (ttm)
-1.13
Shares out
69.48M
Forward P/E
-38.39
YTD return
+22.68%
1-year return
+22.68%
Volume
283.43K
Avg volume
620.88K
Open
28.06
Previous close
28.68
Day's range
26.41 – 28.22
52-week range
18.85 – 39.61
Price target
37.00 (+37.1%)
Earnings date
Feb 2, 2027

Key statistics

50-day average
30.29
200-day average
27.20
Enterprise value
1.94B
Price / sales
17.47
Price / book
6.56
Revenue growth
68.50%
Total cash
226.58M
Total debt
42.35M
Short % of float
5.23%

Fundamental scorecard

3 of 25 checks passed on ALMR’s reported financials

ValueGrowthProfitabilityHealthDividend

3of 25 checks passed

  • Value 0 of 5
  • Growth No data
  • Profitability No data
  • Financial health 3 of 5
  • Dividend No data

Statements to Sep 30, 2026.

Financials — quick view

All financials
ALMR Revenue — quarterly 33.55M
ALMR Net income — quarterly -13.34M
ALMR EPS — quarterly -0.19

Earnings

ALMR recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 2, 2027Dec 30, 2026-0.28———
Nov 3, 2026Sep 30, 2026-0.2015-0.19+0.01+5.71%
Aug 10, 2026Jun 30, 2026-0.30787-0.22+0.09+28.54%
May 8, 2026Mar 31, 2026-1.71-1.74-0.03-1.75%

Upgrades / downgrades

ALMR analyst upgrades and downgrades
DateFirmActionFromTo
Nov 4, 2026TD CowenmainBuyBuy
Aug 11, 2026StifelmainBuyBuy
Aug 11, 2026JP MorganmainOverweightOverweight
May 12, 2026Leerink Partnersinit—Outperform
May 12, 2026TD Coweninit—Buy
May 12, 2026JP Morganinit—Overweight

About Alamar Biosciences, Inc.

Alamar Biosciences, Inc., a proteomics company, develops a proteomic liquid biopsy platform and sells instruments, consumables, and services to early detection of diseases. The company develops NULISA technology, a proteomics platform that detects and quantifies protein biomarkers. It offers ARGO high throughput (HT) System, a fully automated precision proteomics platform, performs ultra-high sensitivity and multiplexed analysis to support biomarker analysis across the continuum of discovery, translational research and ultimately, and diagnostics. The company's offering is utilized in research areas including immunology, neurology, and oncology. It serves global research and academic institutions, biopharmaceutical companies, contract research organizations, and service labs. The company operates in the United States, rest of Europe, Middle East and Africa, Germany, Asia Pacific, and internationally. It has a strategic partnership with Alzheimer's Disease Data Initiative, and Gates Ventures to advance translational research in alzheimer's disease. The company was incorporated in 2018 and is based in Fremont, California.

Sector
Healthcare
Industry
Medical Devices
Country
United States

News

Your note

Sign in to keep a note on ALMR — it syncs with the Stock Master app.

Insider holders

ALMR insider holders
InsiderRelationLatest transactionDateShares held
CHEN SHIPING PH.D.Chief Operating OfficerStock Award(Grant)Apr 19, 2026760,105
ILLUMINA INNOVATION FUND II GP, L.L.C.Beneficial Owner of more than 10% of a Class of SecurityPurchaseApr 19, 20260
LUO YULING PH.D.Chief Executive OfficerStock Award(Grant)Apr 19, 20263,164,730
MCANEAR JUSTIN JChief Financial OfficerStock Award(Grant)Apr 19, 202637,220
NACLERIO NICHOLAS J.DirectorStock Award(Grant)Apr 19, 20266,369,300
QIMING CORPORATE GP VI, LTD.Beneficial Owner of more than 10% of a Class of SecuritySaleNov 10, 20260

Institution ownership

ALMR institution ownership
Holder% heldSharesValueReported
Sands Capital Alternatives, LLC6.09%4,230,926121.34MSep 29, 2026
Samsara BioCapital, LLC3.57%2,480,31071.14MSep 29, 2026
Alliancebernstein L.P.1.80%1,247,64435.78MSep 29, 2026
ARK Investment Management, LLC1.79%1,240,33435.57MSep 29, 2026
Braidwell LP 1.56%1,083,98331.09MSep 29, 2026
HHLR Advisors, LTD1.38%956,46227.43MSep 29, 2026

Fund ownership

ALMR fund ownership
Holder% heldSharesValueReported
ARK ETF Trust-ARK Genomic Revolution ETF1.66%1,156,78433.18MOct 30, 2026
ARK Venture Fund0.96%667,71719.15MJul 30, 2026
AB CAP FUND, INC.-AB Small Cap Growth Portfolio0.85%587,47316.85MSep 29, 2026
Columbia Funds Series Trust I-Columbia Small Cap Growth Fund0.68%472,55413.55MAug 30, 2026
T. Rowe Price Small-Cap Stock Fund, Inc.0.51%355,86410.21MJun 29, 2026
iShares Trust-iShares Russell 2000 ETF0.50%345,0709.90MSep 29, 2026